Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015–2016
Open Access
- 28 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the Pediatric Infectious Diseases Society
- Vol. 10 (2), 75-82
- https://doi.org/10.1093/jpids/piaa017
Abstract
Background Annual United States (US) estimates of influenza vaccine effectiveness (VE) in children typically measure protection against outpatient medically attended influenza illness, with limited data evaluating VE against influenza hospitalizations. We estimated VE for preventing laboratory-confirmed influenza hospitalization among US children. Methods We included children aged 6 months–17 years with acute respiratory illness enrolled in the New Vaccine Surveillance Network during the 2015–2016 influenza season. Documented influenza vaccination status was obtained from state immunization information systems, the electronic medical record, and/or provider records. Midturbinate nasal and throat swabs were tested for influenza using molecular assays. We estimated VE as 100% × (1 – odds ratio), comparing the odds of vaccination among subjects testing influenza positive with subjects testing negative, using multivariable logistic regression. Results Of 1653 participants, 36 of 707 (5%) of those fully vaccinated, 18 of 226 (8%) of those partially vaccinated, and 85 of 720 (12%) of unvaccinated children tested positive for influenza. Of those vaccinated, almost 90% were documented to have received inactivated vaccine. The majority (81%) of influenza cases were in children ≤ 8 years of age. Of the 139 influenza-positive cases, 42% were A(H1N1)pdm09, 42% were B viruses, and 14% were A(H3N2). Overall, adjusted VE for fully vaccinated children was 56% (95% confidence interval [CI], 34%–71%) against any influenza-associated hospitalization, 68% (95% CI, 36%–84%) for A(H1N1)pdm09, and 44% (95% CI, –1% to 69%) for B viruses. Conclusions These findings demonstrate the importance of annual influenza vaccination in prevention of severe influenza disease and of reducing the number of children who remain unvaccinated or partially vaccinated against influenza.Keywords
Funding Information
- Centers for Disease Control and Prevention (CDC-RFA-IP16-004)
This publication has 34 references indexed in Scilit:
- Effectiveness of Influenza Vaccine Against Life-threatening RT-PCR-confirmed Influenza Illness in US Children, 2010–2012The Journal of Infectious Diseases, 2014
- Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in ChildrenNew England Journal of Medicine, 2013
- Field evaluation of TaqMan Array Card (TAC) for the simultaneous detection of multiple respiratory viruses in children with acute respiratory infectionJournal of Clinical Virology, 2013
- Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirusJournal of Clinical Virology, 2012
- Vaccine effectiveness for laboratory-confirmed influenza in children 6–59 months of age, 2005–2007Vaccine, 2011
- FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract InfectionPLOS ONE, 2011
- Application of TaqMan Low-Density Arrays for Simultaneous Detection of Multiple Respiratory PathogensJournal of Clinical Microbiology, 2011
- Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003–2004 and 2004–2005 Influenza SeasonsPublished by American Academy of Pediatrics (AAP) ,2008
- Influenza Vaccine Effectiveness Among Children 6 to 59 Months of Age During 2 Influenza SeasonsArchives of Pediatrics & Adolescent Medicine, 2008
- Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 DosesPublished by American Academy of Pediatrics (AAP) ,2005